Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Research & Development: 2015-2024

Historic Research & Development for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to $9.8 million.

  • Insight Molecular Diagnostics' Research & Development rose 37.66% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 21.83%. This contributed to the annual value of $9.8 million for FY2024, which is 5.86% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Research & Development of $9.8 million as of FY2024, which was up 5.86% from $9.3 million recorded in FY2023.
  • In the past 5 years, Insight Molecular Diagnostics' Research & Development ranged from a high of $9.8 million in FY2024 and a low of $5.0 million during FY2021.
  • Its 3-year average for Research & Development is $8.8 million, with a median of $9.3 million in 2023.
  • In the last 5 years, Insight Molecular Diagnostics' Research & Development crashed by 48.62% in 2021 and then spiked by 45.00% in 2022.
  • Over the past 5 years, Insight Molecular Diagnostics' Research & Development (Yearly) stood at $9.8 million in 2020, then slumped by 48.62% to $5.0 million in 2021, then soared by 45.00% to $7.3 million in 2022, then increased by 27.30% to $9.3 million in 2023, then increased by 5.86% to $9.8 million in 2024.